Boehringer Ingelheim Names New Chairman

From DCAT Value Chain Insights (VCI)

By People On The Move posted 11-10-2015 11:01


Boehringer Ingelheim has announced Professor Andreas Barner, currently chairman of the board of managing directors will retire from that role on June 30, 2016 and will move to the Shareholders' Committee of Boehringer Ingelheim. He will be succeeded by Hubertus von Baumbach, whom the shareholders have appointed as the new chairman of the board of managing directors.

von Baumbach has been a member of the board of managing directors since 2009 and is head of the Corporate Board Division Finance. Following periods at Roche in the US and at Boehringer Ingelheim in Canada, he performed various functions in the finance division at Boehringer Ingelheim in Germany.

After completing his doctorate in medicine and mathematics, Professor Barner joined Boehringer Ingelheim in 1992 as head of the Medical Division. He became a member of the board of managing directors in 1999, and has been chairman since 2009.

From January 1, 2016, Dr Michel Pairet will become a member of the board of managing directors with responsibility for the Corporate Business Division Research and Nonclinical Development. Dr. Pairet studied veterinary medicine in Toulouse, France and came to Boehringer Ingelheim in 1992, where he led the pharmacology unit at the research facility in Biberach. Dr Pairet has taken on ever greater responsibility in the area of research with management roles including respiratory research, the Corporate Venture Fund and, since 2013, worldwide pharmaceutical research and nonclinical development.

Source: Boehringer Ingelheim


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription